MedElevator Войти в исследования
← Поиск публикаций

DOI 10.21470/1678-9741-2020-0267

Медицинская библиотека · Brazilian journal of cardiovascular surgery · 2020

Stentless Root Replacement versus Tissue Valves in Infective Endocarditis - A Propensity-Score Matched Study.

Easo Jerry, Szczechowicz Marcin, Hölzl Philipp, Meyer Adrian, Zhigalov Konstantin, Malik Rizwan, Thomas Rohit Philip, Weymann Alexander, Dapunt Otto E

СтатьяПеревод пока не подготовлен

Аннотация

INTRODUCTION

People with aortic/prosthetic valve endocarditis are a high-risk cohort of patients who present a challenge for all medically involved disciplines and who can be treated by various surgical techniques.

METHODS

We analyzed the results of treatment of root endocarditis with Medtronic Freestyle® in full-root technique over 19 years (1999-2018) and compared them against treatment with other tissue valves. Comparison was made with propensity score matching, using the nearest neighbor method. Various tests were performed as suited for adequate analyses.

RESULTS

Fifty-four patients in the Medtronic Freestyle group (FS group) were matched against 54 complex root endocarditis patients treated with other tissue valves (Tissue group). Hospital mortality was 9/54 (16.7%) in the FS group vs. 14/54 (25.6%) in the Tissue group (P=0.24). Cox regression performed for early results demonstrated coronary heart disease (P=0.004, odds ratio 2.3), among others, influencing early mortality. Recurrent infection was low (1.8% for FS and Tissue patients) and freedom from reoperation was 97.2% at a total of 367 patient-years of follow-up (median of 2.7 years).

CONCLUSION

The stentless xenograft is a viable alternative for treatment of valve/root/prosthetic endocarditis, demonstrating a low rate of reinfection. The design of the bioroot allows for complex reconstructive procedures at the outflow tract and the annular level with at an acceptable operative risk. Endocarditis patients can be treated excluding infective tissue from the bloodstream, possibly with benefits, concerning bacteremia and recurrent infection. Furthermore, the use of the stentless bioroot offers varying treatment options in case of future valve degeneration.

Для цитирования: Easo Jerry, Szczechowicz Marcin, Hölzl Philipp, Meyer Adrian, Zhigalov Konstantin, Malik Rizwan, Thomas Rohit Philip, Weymann Alexander, Dapunt Otto E. Stentless Root Replacement versus Tissue Valves in Infective Endocarditis - A Propensity-Score Matched Study.. Brazilian journal of cardiovascular surgery. 2020. DOI: 10.21470/1678-9741-2020-0267.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.